Close Menu

NEW YORK – MDxHealth reported on Monday that its revenues for the first nine months of 2019 fell 35 percent year over year, primarily as a result of adjustments in accounts receivable, payor mix, and the timing of test kit collections.

For the nine months ended Sept. 30, the diagnostics company reported revenues of $15.6 million, down from $24.0 million in the year-ago period. Product revenues fell 31 percent to $15.3 million from $22.1 million, and income from royalties and patents fell 82 percent to $342,000 from $1.9 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.